Bibliografía

Booth S; HaemSTAR Network; Desborough M, Curry N, Stanworth S. Platelet transfusion and anticoagulation in hematological cancer-associated thrombosis and thrombocytopenia: The CAVEaT multicenter prospective cohort. J Thromb Haemost. 2022 Aug;20(8):1830-8. [PubMed]

Brunson A, Ho G, White R, Wun T. Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE) does not improve clinical outcomes: a population-based study. Thromb Res. 2017 May;153:57-64. [PubMed]

Di Micco P, Monreal M. Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry. J Blood Med. 2019 Dec 31;10:453-6. [PubMed]

Easaw JC, Shea-Budgell MA, Wu CM, Czaykowski PM, Kassis J, Kuehl B, et al. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Curr Oncol. 2015 Apr;22(2):144-55. [PubMed]

Easaw JC, Shea-Budgell MA, Wu CM, Czaykowski PM, Kassis J, Kuehl B, et al. Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 1: prophylaxis. Curr Oncol. 2015 Apr;22(2):133-43. [PubMed]

Falanga A, Leader A, Ambaglio C, Bagoly Z, Castaman G, Elalamy I, et al. EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer. Hemasphere. 2022 Jul 13;6(8):e750. [PubMed]

Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A, et al.; International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2019 Oct;20(10):e566-e581. [PubMed]

Gerber DE, Segal JB, Levy MY, Kane J, Jones RJ, Streiff MB. The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE prevention. Blood. 2008 Aug 1;112(3):504-10. [PubMed]

Ibrahim RB, Skewes MD, Kuriakose P. 'Sailing in troubled waters': a review of the use of anticoagulation in adult cancer patients with thrombocytopenia. Blood Coagul Fibrinolysis. 2016 Sep;27(6):615-30. [PubMed]

Lecumberri R, Ruiz-Artacho P, Trujillo-Santos J, Brenner B, Barillari G, Ruiz-Ruiz J, Lorente MA, Verhamme P, Vázquez FJ, Weinberg I, Monreal M; RIETE Investigators. Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia. Thromb Res. 2020 Nov;195:139-45. [PubMed]

Mantha S, Miao Y, Willis J, Parameswaran R, Soff GA. Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study. J Thromb Thrombolysis. 2017 May;43 (4):514-8. [PubMed]

Pachón V, Trujillo-Santos J, Domènech P, Gallardo E, Font C, González-Porras JR, et al. Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus. TH Open. 2018 Nov 5;2(4):e373-e386. [PubMed]

Patell R, Hsu C, Shi M, Grosso MA, Duggal A, Buller HR, et al. Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer. Haematologica. 2023 Oct 19:0. Epub ahead of print. [PubMed]

Prandoni P, Lensing AW, Piccioli A, Bernardi E, Simioni P, Girolami B, et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood. 2002 Nov 15;100(10):3484-8. [PubMed]

Samuelson Bannow BT, Lee AY, Khorana AA, Zwicker JI, Noble S, Ay C, Carrier M. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost. 2018 Jun;16(6):1246-9. [PubMed]

Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK. Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):165-86. Review. [PubMed]